Literature DB >> 15198193

Two case reports: fatal Absidia corymbifera pulmonary tract infection in the first postoperative phase of a lung transplant patient receiving voriconazole prophylaxis, and transient bronchial Absidia corymbifera colonization in a lung transplant patient.

F Mattner1, H Weissbrodt, M Strueber.   

Abstract

Absidia corymbifera is a rare cause of pulmonary tract infection. There exist only 5 case reports predominantly diagnosed in bone marrow transplant patients. Lung transplant patients are at high risk for invasive fungal infections. Due to A. corymbifera as pathogen, known to be voriconazole resistant, a fatal invasive pulmonary mycosis occurred. In the present case voriconazole prophylaxis failed. A second patient showed a transient colonization of the bronchi. To prevent airborne transmitted invasive pulmonary mycosis in the first postoperative period of lung transplantation the patient should be situated in a room ventilated by HEPA-filtered air. The specific treatment should start very early when first suspicion arises. A review of the literature on pulmonary tract infections induced by Absidia corymbifera is provided.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15198193     DOI: 10.1080/00365540410019408

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  5 in total

Review 1.  Zygomycosis: the re-emerging fungal infection.

Authors:  M Chayakulkeeree; M A Ghannoum; J R Perfect
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-04       Impact factor: 3.267

2.  Mucormycosis in immunochallenged patients.

Authors:  Jane Pak; Veronica T Tucci; Albert L Vincent; Ramon L Sandin; John N Greene
Journal:  J Emerg Trauma Shock       Date:  2008-07

3.  Genetic identification of the main opportunistic Mucorales by PCR-restriction fragment length polymorphism.

Authors:  M Machouart; J Larché; K Burton; J Collomb; P Maurer; A Cintrat; M F Biava; S Greciano; A F A Kuijpers; N Contet-Audonneau; G S de Hoog; A Gérard; B Fortier
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

4.  Primary cutaneous mucormycosis in a patient with burn wounds due to Lichtheimia ramosa.

Authors:  Ravinder Kaur; Kiran Bala; Rajeev B Ahuja; Prabhat Srivastav; Umesh Bansal
Journal:  Mycopathologia       Date:  2014-08-29       Impact factor: 2.574

5.  Voriconazole in the management of nosocomial invasive fungal infections.

Authors:  Javier Pemán; Miguel Salavert; Emilia Cantón; Isidro Jarque; Eva Romá; Rafael Zaragoza; Angel Viudes; Miguel Gobernado
Journal:  Ther Clin Risk Manag       Date:  2006-06       Impact factor: 2.423

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.